OTC Markets OTCPK - Delayed Quote USD

Candriam Eqs L Biotech C USD Cap (0P00000BOM)

933.96 -3.90 (-0.42%)
At close: July 29 at 4:00 PM EDT

Top 10 Holdings (45.76% of Total Assets)

SymbolCompany% Assets
VRTX
Vertex Pharmaceuticals Incorporated 7.32%
REGN
Regeneron Pharmaceuticals, Inc. 7.00%
AMGN
Amgen Inc. 6.68%
MRNA
Moderna, Inc. 4.43%
AZN.L
AstraZeneca PLC 4.13%
GILD
Gilead Sciences, Inc. 3.99%
BIIB
Biogen Inc. 3.67%
LLY
Eli Lilly and Company 3.10%
ALNY
Alnylam Pharmaceuticals, Inc. 2.97%
INCY
Incyte Corporation 2.48%

Sector Weightings

Sector0P00000BOM
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Cash 2.32%
Stocks 97.68%
Bonds 0.00%
Others 0.00%
Preferred 0.00%
Convertible 0.00%

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

Equity Holdings

Average 0P00000BOM Category Average
Price/Earnings 0.03 --
Price/Book 0.24 --
Price/Sales 0.14 --
Price/Cashflow 0.06 --
Median Market Cap 23,061.47 --
3 Year Earnings Growth 7.79 --

Bond Holdings

Performance & Risk

YTD Return 0.00%
5y Average Return 0.00%
Rank in Category (ytd) 21
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.84
Morningstar Risk Rating

Fund Overview

Category --
Fund Family Candriam
Net Assets --
YTD Return 5.67%
Yield 0.00%
Morningstar Rating
Inception Date Mar 08, 2016

Fund Summary

Related Tickers